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Objective: To investigate the protective effect of erythropoietin (EPO) pretreatment on
ischemic acute renal failure in rats and its molecular mechanism.
Methods: Male Sprague–Dawley rats were selected as experimental animals and they
were randomly divided into the sham operation group (sham group), ischemia-reperfusion
injury group (IRI group) and EPO pretreatment group (EPO group). Each group had 15
rats. Serum specimens and renal specimens were collected after a IRI model was built for
4, 12 and 24 h. The contents of creatinine, urea nitrogen tumor necrosis factor-alpha
(TNF-a), interleukin-1 (IL-1), IL-6 and IL-8 in serum and the contents of TNF-a, IL-
1, IL-6, IL-8, toll like receptor 4 (TLR4) and nuclear factor-kappa B (NF-kB) in the
kidney tissue were determined.
Results: After 4, 12 and 24 h reperfusion, there were differences between the contents of
creatinine, urea nitrogen TNF-a, IL-1, IL-6 and IL-8 in serum and the contents of TNF-a,
IL-1, IL-6, IL-8, TLR4 and NF-kB in rats of the three groups (P < 0.05). The contents of
creatinine, urea nitrogen TNF-a, IL-1, IL-6 and IL-8 in serum and the contents of TNF-a,
IL-1, IL-6, IL-8, TLR4 and NF-kB in the kidney tissue in rats of the IRI group were
signiﬁcantly higher than those of the sham group; and the contents of creatinine, urea
nitrogen TNF-a, IL-1, IL-6 and IL-8 in serum and the contents of TNF-a, IL-1, IL-6, IL-
8, TLR4 and NF-kB in the kidney tissue in rats of the EPO group were distinctly lower
than those of the IRI group.
Conclusions: EPO pretreatment can protect the renal function of rats with ischemic acute
renal failure by inhibiting the TLR4/NF-kB pathway mediated inﬂammatory responses.1. Introduction
Acute kidney injury is a clinically troublesome disease mainly
resulted from ischemia causes such as cardiopulmonary bypass,
hemorrhagic shock, vascular occlusion in renal transplantation
and so on. It mainly causes acute ischemic injury through
ischemia-reperfusion injury (IRI)[1–3]. The pathophysiological
procedure of kidney IRI is quite complicated. Cell apoptosis,
oxidative stress, inﬂammatory response and vascular endothelial
injury all participate in the IRI process[4–6]. The excessivelyactivated inﬂammatory responses and the over-compounded in-
ﬂammatory factors play the key role in IRI process and the path-
ological and physiological changes ofmany other related diseases,
which can relieve kidney injury and improve renal function by
inhibiting the activation of inﬂammatory responses[7–9].
Erythropoietin (EPO) is a soluble glycoprotein existing in the
body's circulation. EPO is compounded and secreted by inter-
stitial cells and it can promote the production of erythrocytes. It
was ﬁrst used in the treatment of anemia. Recent researches have
proved that other than the hematopoietic function, EPO also
possesses multiple biological functions which can protect the IRI
of brain[10], heart[11], liver[12,13] and kidney[14]. However, the
concrete molecular mechanism of the protective effect still
remains unclear. Toll like receptors (TLRs) are considered as
the key upstream molecules in the regulation process of
inﬂammatory responses. There are researches conﬁrming that
the expression of TLR4 in tubular epithelial cells increasesunder the CC BY-NC-ND license (http://
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expressions of various inﬂammatory factors by the myeloid
differentiation marker 88-dependent method in the occurrence
process of kidney IRI. In the following researches, we mainly
analyzed whether EPO protects ischemic acute kidney injury by
adjusting the TLR4/NF-kB pathway in the kidney tissue.
2. Materials and methods
2.1. Experimental materials
A total of 45 male Sprague–Dawley rats with speciﬁc path-
ogen free level (weighting 220–250 g) were bought from the
Animal Center of Southern Medical University. The animal
experiment was approved by the hospital's Ethics Committee.
Tumor necrosis factor-alpha (TNF-a), IL-1, IL-6 and IL-8
ELISA kits were purchased from Shanghai Westang Bio-Tech
Co. TLR4 and NF-kB monoclonal antibodies were from
Santa-Cruz and the tissue protein extraction reagent was from
Wuhan Boster Co.
2.2. Animal experimental methods
Those 45 rats were randomly divided into the sham operation
group (sham group), IRI group and EPO group with 15 rats in
each group. Twenty-four hours before building models, rats in
the EPO group were intraperitoneally injected with 3000 IU/kg
EPO, while rats in the sham and IRI groups were intraperito-
neally injected with 3000 IU/kg normal saline. Acute kidney
injury models of the IRI and EPO groups were built by the
following steps. After intraperitoneal anesthesia with 10%
chloral hydrate, a median abdominal incision was made and the
kidney and renal pedicles were dissociated after entering the
enterocoelia. A bulldog clamp was used to clip the bilateral renal
artery. Sixty minutes later, the bulldog clamp was removed and
the renal tissue received reperfusion. Rats in the sham group
were only treated with the opening enterocoelia and dissociating
the renal artery and no bulldog clamp was needed to clip the
blood vessel. After 4, 12 and 24 h reperfusion, 5 rats of each
group were executed to collect blood specimens and kidney
specimens. Serum obtained from centrifugalization of the blood
samples was stored in a refrigerator at −80 C and the renal
tissue was frozen transitorily by liquid nitrogen and then kept in
the fridge at −80 C.
2.3. Index detection methods
Serum samples were collected. The automatic biochemical
analyzer was used to test the contents of serum creatinine (Scr)
and blood urea nitrogen (BUN), while ELISA kits was applied
to detect the contents of TNF-a, IL-1, IL-6 and IL-8. The renal
tissue was obtained and protein extraction was added into it and
then they were grinded and homogenized. After that, the ho-
mogenization was transited into the Eppendorf tube and centri-
fuged and the supernatant was collected. ELISA kits was again
applied to detect the contents of TNF-a, IL-1, IL-6 and IL-8, and
Western blot method was employed to test the expression
quantities of TLR4 and NF-kB. The experiment conditions of
the Western blot method included 130 V vertical electrophoresis
for 80 min, 100 V transfer tank for electrophoresis for 90 min,
2% skim milk in isolation for 2 h, 1:1000 TLR4, incubation byNF-kB monoclonal antibody overnight, incubation by 1:1000
horseradish peroxidase-marked secondary antibody for 1–1.5 h.
Gel electrophoresis imaging system was developed. The gray
value of the protein band and the protein content was calculated.
2.4. Statistical methods
Data were input and analyzed by using SPSS17.0 software.
Measurement data of the three groups were analyzed by One-way
ANOVA. Differences showed statistical signiﬁcance (P < 0.05).
3. Results
3.1. Serum biochemical indexes
After 4, 12 and 24 h reperfusion, the contents of BUN and Scr
of the three groups were different (P< 0.05). The contents of BUN
in the IRI group [(9.42 ± 1.16) vs. (6.82 ± 0.82) mmol/L],
[(32.58 ± 5.29) vs. (7.75 ± 0.92) mmol/L], [(52.31 ± 8.52) vs.
(6.10 ± 0.77) mmol/L] and the contents of Scr [(79.51 ± 9.32) vs.
(35.22± 5.82)mmol/L], [(283.41 ± 42.38) vs. (38.31± 4.39)mmol/
L], [(402.95 ± 62.41) vs. (30.15 ± 5.23) mmol/L] were all signif-
icantly higher than those in the sham group. In the EPO group, the
contents of BUN [(13.29 ± 2.82) vs. (32.58 ± 5.29) mmol/L],
[(21.84 ± 4.18) vs. (52.31 ± 8.52) mmol/L], [(7.64 ± 1.03) vs.
(9.42 ± 1.16) mmol/L] and the contents of Scr [(52.16 ± 7.29) vs.
(79.51 ± 9.32) mmol/L], [(89.32 ± 10.23) vs. (283.41 ± 42.38)
mmol/L], [(128.48 ± 18.52) vs. (402.95 ± 62.41) mmol/L] were all
obviously lower than those in the IRI group (Table 1).
3.2. The contents of serum inﬂammatory factors
After 4, 12 and 24 h reperfusion, the contents of serum TNF-a,
IL-1, IL-6 and IL-8 in the three groupswere different (P< 0.05). In
the IRI group, serum levels of TNF-a [(19.34 ± 3.06) vs.
(10.33 ± 1.68) mg/L], [(48.52 ± 8.25) vs. (13.18 ± 1.71) mg/L],
[(126.64 ± 19.15) vs. (11.38 ± 1.41) mg/L], IL-1 [(40.27 ± 6.72) vs.
(23.51 ± 4.68) mg/L], [(105.38 ± 16.37) vs. (30.42 ± 6.51) mg/L],
[(193.52 ± 25.28) vs. (26.36 ± 3.72) mg/L], IL-6 [(214.42 ± 30.38)
vs. (115.22 ± 17.43) ng/L], [(336.41 ± 50.27) vs. (130.64 ± 22.36)
ng/L], [(477.54 ± 62.51) vs. (109.62 ± 18.45) ng/L] were all
signiﬁcantly higher than those in the sham group. In the EPO
group, the serum levels of TNF-a [(13.65 ± 2.26) vs. (19.34 ± 3.06)
mg/L], [(21.49 ± 3.18) vs. (48.52 ± 8.25) mg/L], [(38.56 ± 6.53) vs.
(126.64 ± 19.15) mg/L], IL-1 [(31.23 ± 5.37) vs. (40.27 ± 6.72) mg/
L], [(50.33 ± 7.85) vs. (105.38 ± 16.37) mg/L], [(84.14 ± 11.38) vs.
(193.52± 25.28)mg/L], IL-6 [(165.63±20.24) vs. (214.42± 30.38)
ng/L], [(336.41 ± 50.27) vs. (189.61 ± 23.42) ng/L], [(477.54
± 62.51) vs. (223.54 ± 34.18) ng/L] were all obviously lower than
those in the IRI group (Table 2).
3.3. The contents of inﬂammatory factors in the kidney
tissue
After 4, 12 and 24 h reperfusion, the contents of TNF-a, IL-1
and IL-6 in the kidney tissue of the three groups were different
(P< 0.05). In the kidney tissue in rats of the IRI group, the contents
of TNF-a [(25.27 ± 5.26) vs. (9.33 ± 1.05) mg/L], [(56.71 ± 9.26)
vs. (10.41 ± 1.76) mg/L], [(113.62 ± 16.76) vs. (10.28 ± 1.55) mg/
L], IL-1 [(33.57± 5.61) vs. (15.78 ± 2.27)mg/L], [(78.32± 9.16) vs.
(17.18 ± 2.89) mg/L], [(146.76 ± 17.85) vs. (16.66 ± 2.47) mg/L],
Table 2
Comparison of the contents of serum inﬂammatory factors in rats of the three groups.
Biochemical indexes Group 4 h 12 h 24 h
TNF-a (mg/L) Sham 10.33 ± 1.68 13.18 ± 1.71 11.38 ± 1.41
IRI 19.34 ± 3.06a 48.52 ± 8.25a 126.64 ± 19.15a
EPO 13.65 ± 2.26b 21.49 ± 3.18b 38.56 ± 6.53b
IL-1 (mg/LA) Sham 23.51 ± 4.68 30.42 ± 6.51 26.36 ± 3.72
IRI 40.27 ± 6.72a 105.38 ± 16.37a 193.52 ± 25.28a
EPO 31.23 ± 5.37b 50.33 ± 7.85b 84.14 ± 11.38b
IL-6 (ng/L) Sham 115.22 ± 17.43 130.64 ± 22.36 109.62 ± 18.45
IRI 214.42 ± 30.38a 336.41 ± 50.27a 477.54 ± 62.51a
EPO 165.63 ± 20.24b 189.61 ± 23.42b 223.54 ± 34.18b
Compared with the sham group, a: P < 0.05; Compared with the IRI group, b: P < 0.05.
Table 1
Comparison of the serum biochemical indexes of the three groups.
Biochemical indexes Group 4 h 12 h 24 h
BUN (mmol/L) Sham 6.82 ± 0.82 7.75 ± 0.92 6.10 ± 0.77
IRI 9.42 ± 1.16a 32.58 ± 5.29a 52.31 ± 8.52a
EPO 7.64 ± 1.03b 13.29 ± 2.82b 21.84 ± 4.18b
Scr (mmol/L) Sham 35.22 ± 5.82 38.31 ± 4.39 30.15 ± 5.23
IRI 79.51 ± 9.32a 283.41 ± 42.38a 402.95 ± 62.41a
EPO 52.16 ± 7.29b 89.32 ± 10.23b 128.48 ± 18.52b
Compared with the sham group, a: P < 0.05; Compared with the IRI group, b: P < 0.05.
Table 4
Comparison of the contents of inﬂammatory factors in the kidney tissue
of the three groups.
Biochemical
indexes
Group 4 h 12 h 24 h
TLR4 Sham 1.00 ± 0.16 1.16 ± 0.14 1.08 ± 0.11
IRI 1.83 ± 0.27a 3.18 ± 0.52a 4.46 ± 0.74a
EPO 1.39 ± 0.22b 1.78 ± 0.24b 2.52 ± 0.34b
NF-kB Sham 1.00 ± 0.14 1.12 ± 0.15 1.17 ± 0.18
IRI 1.95 ± 0.24a 3.36 ± 0.49a 4.85 ± 0.71a
EPO 1.28 ± 0.17b 1.66 ± 0.20b 2.37 ± 0.40b
Compared with the sham group, a: P < 0.05; Compared with the IRI
group, b: P < 0.05.
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[(514.64 ± 76.85) vs. (150.12 ± 19.57) ng/L], [(883.25 ± 104.57)
vs. (147.75 ± 20.36) ng/L] were all apparently higher than those of
the sham group. In the kidney tissue in rats of the EPO group, the
contents of TNF-a [(13.17 ± 2.14) vs. (25.27 ± 5.26) mg/L],
[(22.12 ± 3.49) vs. (56.71 ± 9.26) mg/L], [(40.29 ± 6.92) vs.
(113.62 ± 16.76) mg/L], IL-1 [(22.15 ± 3.49) vs. (33.57 ± 5.61) mg/
L], [(34.48 ± 5.18) vs. (78.32 ± 9.16) mg/L], [(42.56 ± 6.23) vs.
(146.76 ± 17.85) mg/L], IL-6 [(188.32 ± 22.63) vs. (277.65
± 34.15) ng/L], [(247.86 ± 32.69) vs. (514.64 ± 76.85) ng/L],
[(304.61 ± 46.20) vs. (883.25 ± 104.57) ng/L] were all evidently
lower than those of the IRI group (Table 3).
3.4. The contents of TLR4/NF-kB in the kidney tissue
After 4, 12 and 24 h reperfusion, the contents of TLR4 and NF-
kB in the kidney tissue in rats of the three groups were different
(P< 0.05). In the kidney tissue in rats of the IRI group, the contents
of TLR4 [(1.83 ± 0.27) vs. (1.00 ± 0.16)], [(3.18 ± 0.52) vs.
(1.16 ± 0.14)], [(4.46 ± 0.74) vs. (1.08 ± 0.11)] and NF-kB
[(1.95 ± 0.24) vs. (1.00 ± 0.14)], [(3.36 ± 0.49) vs. (1.12 ± 0.15)],
[(4.85 ± 0.71) vs. (1.17 ± 0.18)] were all signiﬁcantly higher than
those of the sham group. In the kidney tissue in rats of the EPO
group, the contents of TLR4 [(1.39 ± 0.22) vs. (1.83 ± 0.27)],Table 3
Comparison of the contents of inﬂammatory factors in the kidney tissue of t
Biochemical indexes Group 4 h
TNF-a (mg/L) Sham 9.33 ± 1.05
IRI 25.27 ± 5.26
EPO 13.17 ± 2.14
IL-1 (mg/L) Sham 15.78 ± 2.27
IRI 33.57 ± 5.61
EPO 22.15 ± 3.49
IL-6 (ng/L) Sham 142.97 ± 22.7
IRI 277.65 ± 34.1
EPO 188.32 ± 22.6
Compared with the sham group, a: P < 0.05; Compared with the IRI group[(1.78 ± 0.24) vs. (3.18 ± 0.52)], [(2.52 ± 0.34) vs. (4.46 ± 0.74)]
and NF-kB [(1.28 ± 0.17) vs. (1.95 ± 0.24)], [(1.66 ± 0.20) vs.
(3.36 ± 0.49)], [(2.37 ± 0.40) vs. (4.85 ± 0.71)] were all obviously
lower than those of the IRI group (Table 4).4. Discussion
In this study, acute ischemic renal injury was simulated by
building a kidney IRI model. Creatinine and urea nitrogen arehe three groups.
12 h 24 h
10.41 ± 1.76 10.28 ± 1.55
a 56.71 ± 9.26a 113.62 ± 16.76a
b 22.12 ± 3.49b 40.29 ± 6.92b
17.18 ± 2.89 16.66 ± 2.47
a 78.32 ± 9.16a 146.76 ± 17.85a
b 34.48 ± 5.18b 42.56 ± 6.23b
8 150.12 ± 19.57 147.75 ± 20.36
5a 514.64 ± 76.85a 883.25 ± 104.57a
3b 247.86 ± 32.69b 304.61 ± 46.20b
, b: P < 0.05.
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metabolized mainly through the kidney. When the renal function
is injured beyond its compensative capacity, the levels of BUN
and Scr increase obviously. The contents of BUN and Scr are
used to evaluate renal function and reﬂect the renal injury degree
in clinic. In this study, a kidney IRI model was established by
clipping ﬁrst and then opening the renal artery. It was found by
analyzing the contents of BUN and Scr within 24 h after
reperfusion that the contents of BUN and Scr in rats of the IRI
after 4, 12 and 24 h reperfusion rose signiﬁcantly, which indi-
cated that the kidney tissue was injured after experiencing
ischemia reperfusion and thus greatly weakened the discharge
capacity for creatinine and urea nitrogen. EPO plays a positive
role in promoting the hematopoiesis of the myeloid tissue, which
was ﬁrst used to treat anemia. In recent years, studies on the
biological effect of EPO have manifested that EPO can protect
IRI of multiple tissues such as brain[10], heart[11], liver[3,12] and
kidney[14]. In this study, EPO pretreatment was given before
building a kidney IRI model. It was found by analyzing the
contents of BUN and Scr that the content of BUN and Scr
after 4, 12 and 24 h reperfusion in rats of the EPO group were
all lower than those of the IRI group, which veriﬁed that EPO
contains a protective effect on the kidney IRI.
At present, there was no uniﬁed understanding of the path-
ogenesis of IRI. Cell apoptosis, oxidative stress, inﬂammatory
response and vascular endothelial injury are all physiopathologic
changes in the procedure of IRI. Thereinto, inﬂammatory
response caused by ischemia reperfusion is an important path-
ological link in the procedure. A large number of the gathered
inﬂammatory cells and the inﬂammatory factors can induce cell
apoptosis, enhance oxidative stress and aggravate vascular
endothelial injury[15]. TNF-a, IL-1 and IL-6 are important in-
ﬂammatory mediators in the body[16–18]. After analyzing the
contents of the above inﬂammatory mediators in serum and
renal tissue in rats of the three group, it was conﬁrmed that
the contents of TNF-a, IL-1 and IL-6 in serum and renal tis-
sue increased after IRI, while EPO pretreatment could obviously
reduce the contents of TNF-a, IL-1 and IL-6 in serum and renal
tissue. Therefore, it could be concluded that the substantially
produced inﬂammatory mediators is the key step causing kidney
IRI, and EPO could relieve the kidney injury caused by IRI by
inhibiting the production of inﬂammatory mediators. To date,
the regulatory mechanism of inﬂammatory mediators in the
process of kidney IRI is not clear. TLRs is a kind of pattern
recognition receptor which can activate tumor necrosis factor
receptor associated factor-6 by connecting molecules TIR
domain-containing adaptor protein and myeloid differentiation
marker 88 and then activate NF-kB and make it transfer into the
nucleus. After entering the nucleus, NF-kB can promote the
transcriptions of TNF-a, IL-1 and IL-6[19–21]. The analysis of the
expression quantities of TLR4 and NF-kB in the kidney tissue
conﬁrmed that the expression quantities of TLR4 and NF-kB
in the kidney tissue after ischemia reperfusion were elevated,
while the expression of TLR4 and NF-kB can be inhibited
after EPO pretreatment, which can be included that TLR4/NF-
kB is the important mechanism of inﬂammatory responses
mediating the process of kidney IRI. EPO can reduce the
synthesis of inﬂammatory factors by inhibiting the TLR4/NF-
kB pathway so as to alleviate kidney IRI.
In conclusion, EPO pretreatment can protect the renal func-
tion of rats with ischemic acute kidney failure by inhibiting the
TLR4/NF-kB pathway mediated inﬂammatory responses.Conﬂict of interest statement
The authors report no conﬂict of interest.
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